Agilent Technologies, Inc. (A)
$
113.51
+0.53 (0.47%)
Key metrics
Financial statements
Free cash flow per share
3.5088
Market cap
32.1 Billion
Price to sales ratio
4.5443
Debt to equity
0.4855
Current ratio
2.0658
Income quality
1.0822
Average inventory
1 Billion
ROE
0.1973
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilent Technologies, Inc. provides application-focused solutions to life sciences, diagnostics, and applied chemical markets globally. The Life Sciences and Applied Markets segment delivers a wide array of analytical instruments and systems, including liquid chromatography systems and components, mass spectrometry systems, gas chromatography systems, and various spectroscopy technologies. The company's innovative approach is evident in its diverse offerings such as cell analysis plate-based assays, flow cytometers, laboratory automation tools, and dissolution testing equipment. Additionally, Agilent incurred an interest expense of $112,000,000.00 reflecting its debt servicing obligations. The gross profit ratio is 0.52 which highlights the efficiency of the company's production and sales operations. Furthermore, the diluted EPS is $4.57 accounting for potential share dilution, while the net income ratio stands at 0.19 demonstrating the company's profitability margin. The reported depreciation and amortization expenses amount to $288,000,000.00 underscoring the wear and tear of its assets. On the diagnostics front, Agilent offers advanced technologies for DNA analysis, including arrays for mutation detection and next-generation sequencing, along with reagents for turbidimetry. In addition, Agilent CrossLab segment delivers essential laboratory supplies and services such as custom chemistries and sample preparation products. The stock is reasonably priced at $126.32 appealing to a broad range of investors. With a high average trading volume of 2,251,625.00 there is strong liquidity in the stock, making it an attractive option for market participants. The company showcases a mid-range market capitalization of $32,105,129,580.00 positioning it as a steady performer within the sector. As a key player in the Medical - Diagnostics & Research industry, Agilent significantly contributes to the overall market landscape, driving innovation and growth within the Healthcare sector. Its comprehensive range of products is marketed through direct sales, distributors, and electronic commerce, ensuring a broad reach in delivering its advanced solutions to a global clientele.
Is Agilent Technologies, Inc. (A) a good investment?
Investing in Agilent Technologies, Inc. (A) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as A-, with a Bullish outlook. Always conduct your own research before investing.
What is Agilent Technologies, Inc. (A)'s stock forecast?
Analysts predict Agilent Technologies, Inc. stock to fluctuate between $96.43 (low) and $160.27 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilent Technologies, Inc.'s market capitalization?
As of 2026-03-27, Agilent Technologies, Inc.'s market cap is $32,105,129,580, based on 282,839,658 outstanding shares.
How does Agilent Technologies, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Agilent Technologies, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Agilent Technologies, Inc. pay dividends?
Agilent Technologies, Inc. pays dividends. The current dividend yield is 0.89%, with a payout of $0.26 per share.
How can I buy Agilent Technologies, Inc. (A) stock?
To buy Agilent Technologies, Inc. (A) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for A. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilent Technologies, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
Has Agilent Technologies, Inc. stock ever split?
Agilent Technologies, Inc.'s last stock split was 699:500 on 2014-11-03.
How did Agilent Technologies, Inc. perform in the last earnings report?
Revenue: $6,948,000,000 | EPS: $4.59 | Growth: 3.38%.
Where can I find Agilent Technologies, Inc.'s investor relations reports?
Visit https://www.agilent.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilent Technologies, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilent Technologies, Inc. stock?
All-time high: $179.57 (2021-09-03) | All-time low: $96.43 (2025-04-09).
What are the key trends affecting Agilent Technologies, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
seekingalpha.com
Agilent Technologies, Inc. (A) Shareholder/Analyst Call Prepared Remarks Transcript
reuters.com
Life sciences firm Agilent Technologies said on Monday that it will acquire clinical pathology firm Biocare Medical in an all-cash deal valued at $950 million.
businesswire.com
SANTA CLARA, Calif. & SAN FRANCISCO, Calif.--(BUSINESS WIRE)---- $A #BringGreatScienceToLife--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million. Biocare is a high-growth global pathology antibody leader, serving customers with a complementary portfolio of immunohistochemistry (IHC), in sit.
seekingalpha.com
Agilent Technologies, Inc. (A) Presents at TD Cowen 46th Annual Health Care Conference Transcript
zacks.com
A posts Q1 revenue growth and beats sales estimates, but margin pressure and earnings miss send shares lower in pre-market trade.
seekingalpha.com
Agilent Technologies, Inc. (A) Q1 2026 Earnings Call Transcript
zacks.com
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended January 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zacks.com
Agilent Technologies (A) came out with quarterly earnings of $1.36 per share, missing the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $1.31 per share a year ago.
reuters.com
Life sciences firm Agilent Technologies on Wednesday reported first-quarter results that were largely in line with Wall Street estimates on stable demand for its medical tools and equipment used in lab research and diagnostic services.
seekingalpha.com
Bloomberg's 2026 Dividend Focus list highlights 16 'safer' stocks with free cash flow yields exceeding dividend yields, signaling strong dividend sustainability. Top projected net gains for 2026 include PT Telekom at 70.36%, with average net gain estimates of 28.13% across the top ten dividend-focused stocks. Five 'IDEAL' stocks—Continental, Aviva, PT Telekom, Danske Bank, and Western Midstream—offer dividends from $1,000 invested that exceed their single share price.
See all news
